Showing results (541-550 of 889) with videos related to

Sort By:
Pageof 89
Current Anthropology|December 17, 2008
Sex-Specific Genetic Data Support One of Two Alternative Versions of the Foundation of the Ruling Dynasty of the Nso' in CameroonKrishna R Veeramah, David Zeitlyn, Verkijika G Fanso, et al.
Molecular Therapy. Methods & Clinical Development|March 26, 2021
Adeno-associated virus serotype 9 antibodies in patients screened for treatment with onasemnogene abeparvovecJohn W Day, Richard S Finkel, Eugenio Mercuri, et al.
FEMS Immunology and Medical Microbiology|November 15, 2011
Vγ4+ T cells regulate host immune response to West Nile virus infectionThomas Welte, Judith Aronson, Bin Gong, et al.
Human Gene Therapy|January 5, 2021
Dose-Escalation Study of Systemically Delivered rAAVrh74.MHCK7.micro-dystrophin in the <i>mdx</i> Mouse Model of Duchenne Muscular DystrophyRachael A Potter, Danielle A Griffin, Kristin N Heller, et al.
Muscle & Nerve|October 28, 2006
Challenges in drug development for muscle disease: a stakeholders' meetingJerry R Mendell, Cristina Csimma, Craig M McDonald, et al.
Muscle & Nerve|October 15, 1998
Study of mitochondrial DNA depletion in muscle by single-fiber polymerase chain reactionM Sciacco, P Gasparo-Rippa, T H Vu, et al.
Molecular Therapy. Methods & Clinical Development|February 8, 2024
Use of plasmapheresis to lower anti-AAV antibodies in nonhuman primates with pre-existing immunity to AAVrh74Rachael A Potter, Ellyn L Peterson, Danielle Griffin, et al.
Journal of Market Access & Health Policy|June 1, 2023
Assessing the value of delandistrogene moxeparvovec (SRP-9001) gene therapy in patients with Duchenne muscular dystrophy in the United StatesAlexa C Klimchak, Lauren E Sedita, Louise R Rodino-Klapac, et al.
Annals of Neurology|February 1, 1997
Deletion and conversion in spinal muscular atrophy patients: is there a relationship to severity?C J DiDonato, S E Ingraham, J R Mendell, et al.
Pageof 89